As of 2025-07-07, the Intrinsic Value of Amarantus Bioscience Holdings Inc (AMBS) is -0.36 USD. This AMBS valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Amarantus Bioscience Holdings Inc is -36,359,350.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, Amarantus Bioscience Holdings Inc (AMBS) is overvalued by 36,359,350.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.36 - -0.36 | -0.36 | -36,359,350.00% |
| DDM - Stable | (0.00) - (0.00) | (0.00) | -10048.1% |
| DDM - Multi | (0.00) - (0.00) | (0.00) | -126.7% |
| Market Cap (mil) | 0.00 |
| Beta | 100.30 |
| Outstanding shares (mil) | 368.41 |
| Enterprise Value (mil) | 2.89 |
| Market risk premium | 4.60% |
| Cost of Equity | 71,161.46% |
| Cost of Debt | 5.00% |
| WACC | 5.11% |